3rd Quarter - Report

CALIFORNIA LIFE SCIENCES for CALIFORNIA LIFE SCIENCES

Firm
Client
Income
—
Expenses
$250,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Labor/HHS/Ed Appropriations: Drug Pricing; FDA; NIH; biodefense/pandemic; CDC; science/math education; U.S. Preventive Services Task Force; eLabeling; Orphan Drug Tax Credit Support legislation to reform Congressional Budget Office scoring of health care legislation

LobbyistCovered position, as disclosed
CHRISTOPHER CUNNINGHAM —
BRENTON J. FISK New —
ANTHONY THEISSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Support FDA user fee programs and review process consistency and predictability. Support FDA modernization practices Support legislation proposing coverage for multicancer screening Oppose domestic manufacturing/procurement mandates for pharmaceutical products, APIs, & medical devices Support public education campaign on pandemic preparedness Oppose drug importation proposals Support diversity in clinical trial policy Support medical device change control plans legislation Oppose legislation that expands Medicare Drug Pricing Negotiation Program Support bipartisan Pandemics and All Hazards Preparedness Reauthorization Support bipartisan effort to address health care workforce shortage Support incentives for antimicrobial resistance development (PASTEUR Act) Support legislation providing for e-labeling of medical devices

LobbyistCovered position, as disclosed
CHRISTOPHER CUNNINGHAM —
BRENTON J. FISK New —
ANTHONY THEISSEN —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Natl Institutes of Health (NIH)

Medicare/Medicaid MMM

Support reforms to enable Value Based Healthcare, including reforms to Anti-Kickback Statute & Stark Law Oppose legislative proposal to reform Patent system and Intellectual Property issues impacting the life sciences ecosystem Oppose drug importation proposals Support capping Medicare beneficiary out of pocket costs Support expanded access to telehealth Support value-based purchasing provision, but oppose line extensions and co-pay assistance provisions of CMS Medicaid VBP proposed rule Implement Medicare Drug Price Negotiation program in least harmful way - MFP at ceiling for innovative products, broad orphan drug exclusion, welcome patient and stakeholder input

LobbyistCovered position, as disclosed
CHRISTOPHER CUNNINGHAM —
BRENTON J. FISK New —
ANTHONY THEISSEN —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Taxation/Internal Revenue Code TAX

Support R&D and NOL tax incentives, Orphan Drug Tax Credits, repeal R&D tax amortization

LobbyistCovered position, as disclosed
CHRISTOPHER CUNNINGHAM —
BRENTON J. FISK New —
ANTHONY THEISSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Support NIH research funding Support promulgation of TCET rule Support breakthrough device coverage bill Support bipartisan PAHPA reauthorization

LobbyistCovered position, as disclosed
CHRISTOPHER CUNNINGHAM —
BRENTON J. FISK New —
ANTHONY THEISSEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Copyright/Patent/Trademark CPT

Address concerns with provisions of patent litigation reform, including inter partes review Oppose "march-in" rights and "compulsory licensing" proposals Support transferable exclusivity extensions to incentivize novel antibiotic R&D

LobbyistCovered position, as disclosed
CHRISTOPHER CUNNINGHAM —
BRENTON J. FISK New —
ANTHONY THEISSEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Trade (domestic/foreign) TRD

Oppose proposals to reduce data exclusivity Oppose proposals to restrict data uses Oppose WTO TRIPS waiver for COVID diagnostics and therapeutics

LobbyistCovered position, as disclosed
CHRISTOPHER CUNNINGHAM —
BRENTON J. FISK New —
ANTHONY THEISSEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.